During the past decade, Städtisches Klinikum Dessau conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 4 clinical trials were completed, i.e. on average, 21.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Städtisches Klinikum Dessau" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "AGO Research GmbH" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "North Eastern German Society of Gynaecological Oncology" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Städtisches Klinikum Dessau" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Städtisches Klinikum Dessau" are "Ovarian Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Follicular Lymphoma" (2 trials), "Hidradenitis Suppurativa" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Städtisches Klinikum Dessau" in a lesser frequency.

Most popular intervention types in "Städtisches Klinikum Dessau" are "Drug" (26 trials), "Biological" (6 trials), "Procedure" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Obinutuzumab" (4 trials), "Bendamustine" (3 trials), "Cyclophosphamide" (3 trials) and "Doxorubicin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Städtisches Klinikum Dessau" are 22 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Städtisches Klinikum Dessau". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Städtisches Klinikum Dessau, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Städtisches Klinikum Dessau, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".